Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.
about
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.Medication-induced diabetes during induction treatment for ALL, an early marker for future metabolic risk?Metformin and blood cancers
P2860
Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Medication induced diabetes du ...... k factors and characteristics.
@en
Medication induced diabetes du ...... k factors and characteristics.
@nl
type
label
Medication induced diabetes du ...... k factors and characteristics.
@en
Medication induced diabetes du ...... k factors and characteristics.
@nl
prefLabel
Medication induced diabetes du ...... k factors and characteristics.
@en
Medication induced diabetes du ...... k factors and characteristics.
@nl
P2093
P2860
P1476
Medication induced diabetes du ...... k factors and characteristics.
@en
P2093
Ahmed Naqvi
Dror Koltin
Lillian Sung
Stacey L Urbach
P2860
P2888
P304
P356
10.1007/S00520-011-1307-5
P577
2011-11-08T00:00:00Z
P6179
1002400370